Global Gastro Esophageal Reflux Disease (GERD) Drug Market Report 2020: Brief Analysis by Top Key Players, Segment and Forecast 2026

Published On: Mar 2020

Format: PDF

Publisher: QY Research

Pages: 93

Report ID: 121942


The global Gastro Esophageal Reflux Disease (GERD) Drug market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026.
This report focuses on Gastro Esophageal Reflux Disease (GERD) Drug volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Gastro Esophageal Reflux Disease (GERD) Drug market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Gastro Esophageal Reflux Disease (GERD) Drug market is segmented into
H2 Receptor Antagonist
Proton Pump Inhibitor (PPi)
Antacids

Segment by Application
Hospital
Clinic
Medical Center
Others

Global Gastro Esophageal Reflux Disease (GERD) Drug Market: Regional Analysis
The Gastro Esophageal Reflux Disease (GERD) Drug market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Gastro Esophageal Reflux Disease (GERD) Drug market report are:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Global Gastro Esophageal Reflux Disease (GERD) Drug Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Gastro Esophageal Reflux Disease (GERD) Drug market include:
Pfizer
Novartis AG
GlaxoSmithKline
Merck
Medtronic

Table of Contents

1 Gastro Esophageal Reflux Disease (GERD) Drug Market Overview
1.1 Product Overview and Scope of Gastro Esophageal Reflux Disease (GERD) Drug
1.2 Gastro Esophageal Reflux Disease (GERD) Drug Segment by Type
1.2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 H2 Receptor Antagonist
1.2.3 Proton Pump Inhibitor (PPi)
1.2.4 Antacids
1.3 Gastro Esophageal Reflux Disease (GERD) Drug Segment by Application
1.3.1 Gastro Esophageal Reflux Disease (GERD) Drug Sales Comparison by Application: 2020 VS 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Medical Center
1.3.5 Others
1.4 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size Estimates and Forecasts
1.4.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue 2015-2026
1.4.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales 2015-2026
1.4.3 Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Region: 2020 Versus 2026

2 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Competition by Manufacturers
2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Manufacturers (2015-2020)
2.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Manufacturers (2015-2020)
2.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Gastro Esophageal Reflux Disease (GERD) Drug Manufacturing Sites, Area Served, Product Type
2.5 Gastro Esophageal Reflux Disease (GERD) Drug Market Competitive Situation and Trends
2.5.1 Gastro Esophageal Reflux Disease (GERD) Drug Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Gastro Esophageal Reflux Disease (GERD) Drug Players (Opinion Leaders)

3 Gastro Esophageal Reflux Disease (GERD) Drug Retrospective Market Scenario by Region
3.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Gastro Esophageal Reflux Disease (GERD) Drug Market Facts & Figures by Country
3.3.1 North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country
3.3.2 North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Gastro Esophageal Reflux Disease (GERD) Drug Market Facts & Figures by Country
3.4.1 Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country
3.4.2 Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region
3.5.2 Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Gastro Esophageal Reflux Disease (GERD) Drug Market Facts & Figures by Country
3.6.1 Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country
3.6.2 Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country
3.7.2 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Gastro Esophageal Reflux Disease (GERD) Drug Historic Market Analysis by Type
4.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type (2015-2020)
4.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Type (2015-2020)
4.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Price Market Share by Type (2015-2020)
4.4 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Gastro Esophageal Reflux Disease (GERD) Drug Historic Market Analysis by Application
5.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application (2015-2020)
5.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Application (2015-2020)
5.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Price by Application (2015-2020)

6 Company Profiles and Key Figures in Gastro Esophageal Reflux Disease (GERD) Drug Business
6.1 Pfizer
6.1.1 Corporation Information
6.1.2 Pfizer Description, Business Overview and Total Revenue
6.1.3 Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Pfizer Products Offered
6.1.5 Pfizer Recent Development
6.2 Novartis AG
6.2.1 Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Production Sites and Area Served
6.2.2 Novartis AG Description, Business Overview and Total Revenue
6.2.3 Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Novartis AG Products Offered
6.2.5 Novartis AG Recent Development
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Production Sites and Area Served
6.3.2 GlaxoSmithKline Description, Business Overview and Total Revenue
6.3.3 GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2015-2020)
6.3.4 GlaxoSmithKline Products Offered
6.3.5 GlaxoSmithKline Recent Development
6.4 Merck
6.4.1 Merck Gastro Esophageal Reflux Disease (GERD) Drug Production Sites and Area Served
6.4.2 Merck Description, Business Overview and Total Revenue
6.4.3 Merck Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Merck Products Offered
6.4.5 Merck Recent Development
6.5 Medtronic
6.5.1 Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Production Sites and Area Served
6.5.2 Medtronic Description, Business Overview and Total Revenue
6.5.3 Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Medtronic Products Offered
6.5.5 Medtronic Recent Development

7 Gastro Esophageal Reflux Disease (GERD) Drug Manufacturing Cost Analysis
7.1 Gastro Esophageal Reflux Disease (GERD) Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Gastro Esophageal Reflux Disease (GERD) Drug
7.4 Gastro Esophageal Reflux Disease (GERD) Drug Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Gastro Esophageal Reflux Disease (GERD) Drug Distributors List
8.3 Gastro Esophageal Reflux Disease (GERD) Drug Customers

9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis

10 Global Market Forecast
10.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Gastro Esophageal Reflux Disease (GERD) Drug by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Gastro Esophageal Reflux Disease (GERD) Drug by Type (2021-2026)
10.2 Gastro Esophageal Reflux Disease (GERD) Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Gastro Esophageal Reflux Disease (GERD) Drug by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Gastro Esophageal Reflux Disease (GERD) Drug by Application (2021-2026)
10.3 Gastro Esophageal Reflux Disease (GERD) Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Gastro Esophageal Reflux Disease (GERD) Drug by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Gastro Esophageal Reflux Disease (GERD) Drug by Region (2021-2026)
10.4 North America Gastro Esophageal Reflux Disease (GERD) Drug Estimates and Projections (2021-2026)
10.5 Europe Gastro Esophageal Reflux Disease (GERD) Drug Estimates and Projections (2021-2026)
10.6 Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Estimates and Projections (2021-2026)
10.7 Latin America Gastro Esophageal Reflux Disease (GERD) Drug Estimates and Projections (2021-2026)
10.8 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Estimates and Projections (2021-2026)
11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer